A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
Blood-brain barrier (BBB) models are often used to investigate BBB function and screen brain-penetrating therapeutics, but it has been difficult to construct a human model that possesses an optimal BBB phenotype and is readily scalable. To address this challenge, we developed a human in vitro BBB model comprising brain microvascular endothelial cells (BMECs), pericytes, astrocytes and neurons derived from renewable cell sources. First, retinoic acid (RA) was used to substantially enhance BBB phenotypes in human pluripotent stem cell (hPSC)-derived BMECs, particularly through adherens junction, tight junction, and multidrug resistance protein regulation. RA-treated hPSC-derived BMECs were subsequently co-cultured with primary human brain pericytes and human astrocytes and neurons derived from human neural progenitor cells (NPCs) to yield a fully human BBB model that possessed significant tightness as measured by transendothelial electrical resistance (~5,000 Ωxcm(2)). Overall, this scalable human BBB model may enable a wide range of neuroscience studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Other studies have shown mixed results regarding the effect of pericytes or other supporting cell types on TEER of dhBMEC monolayers [20, 33, 36, 41, 52–54].”
From Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D (2019) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Pericytes are required for blood–brain barrier integrity during embryogenesis
Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128
Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line
Weksler, B. B., Subileau, E. A., Perrière, N., Charneau, P., Holloway, K., Leveque, M., Tricoire‐Leignel, H., Nicotra, A., Bourdoulous, S., Turowski, P., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3458fje · Cited by 1,330
Central nervous system pericytes in health and disease
Winkler, E. A., Bell, R. D., & Zlokovic, B. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2946 · Cited by 962
A Membrane Receptor for Retinol Binding Protein Mediates Cellular Uptake of Vitamin A
Kawaguchi, R., Yu, J., Honda, J., Hu, J., Whitelegge, J., Ping, P., Wiita, P., Bok, D., & Sun, H. (2007) · Science · doi:10.1126/science.1136244 · Cited by 836
Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells
Lippmann, E. S., Azarin, S. M., Kay, J. E., Nessler, R. A., Wilson, H. K., Al-Ahmad, A., Palecek, S. P., & Shusta, E. V. (2012) · Nature Biotechnology · doi:10.1038/nbt.2247 · Cited by 800
Self-citationElectrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.
Butt, A. M., Jones, H. C., & Abbott, N. J. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018243 · Cited by 775
A cell culture model of the blood-brain barrier.
Rubin, L. L., Hall, D. E., Porter, S., Barbu, K., Cannon, C., Horner, H. C., Janatpour, M., Liaw, C. W., Manning, K., & Morales, J. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.6.1725 · Cited by 765
Cited by
Items 401–500 of 547
Weber, C. M., Moiz, B., Kheradmand, M., Scott, A., Kettula, C., Wunderler, B., Vargas, V. A., & Clyne, A. M. (2025) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241310729 · Cited by 2
Identification of Cell Fate Determining Transcription Factors for Generating Brain Endothelial Cells
Ramezankhani, R., Smedt, J. D., Toprakhisar, B., van der Veer, B. K., Tricot, T., Vanmarcke, G., Balaton, B. P., van Grunsven, L. A., Vosough, M., Chai, Y. C., et al. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10842-7 · Cited by 2
“We also used datasets from in vitro cultured primary human BMECs [22], day 11 induced (i)BMECs (based on [16, 22], rECs (reprogrammed Epi-iBMECs with ETV2 , ERG , and FLI1 ) [22] (Supplementary Fig.”
Runwal, P., Pyun, J., Newman, S. A., Mawal, C., Bush, A. I., Koehn, L. M., & Nicolazzo, J. A. (2025) · Pharmaceutical Research · doi:10.1007/s11095-025-03826-2 · Cited by 2
“MBECs were grown in 6-well plates to 80% confluency, then passaged onto Transwell (0.4 µm, polyester) inserts within a 24-well plate coated with 100 µL containing 40% (v/v) Type IV collagen, 10% v/v fibronectin and 50% v/v UltraPure™ distilled water [37].”
InfluentialAlexander, N. G., Buchanan, K. A., Meyer, A. E., Mitterway, L. M., Vanderburgh, C., Rao, S. S., & Kim, B. J. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1516669 · Cited by 2
Nosratabadi, F., Endres, L. M., Schumacher, F., Claus, H., Kleuser, B., Kim, B. J., & Schubert‐Unkmeir, A. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00687-0 · Cited by 2
“S1C) [36, 37, 55].”
Mauser, H. D., Keyzer, T. E., Surma, J. M., Alexander, N. G., Cutts, W. D., Hathcock, S. F., Lackey, K., Lam, D. W., Thornton, J. A., Vollmuth, N., et al. (2025) · Virulence · doi:10.1080/21505594.2025.2564281 · Cited by 2
Wu, Y., Lehtonen, Š., Kauppinen, R., Dhungana, H., Koıstınaho, J., & Rõlova, T. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00728-8 · Cited by 2
“The expression of TJPs and barrier properties are subsequently induced by adding vascular endothelial growth factor (VEGF), Wnt3, or retinoic acid [6, 24, 40].”
Jeong, S., & Kim, K.-M. (2026) · BioChip Journal · doi:10.1007/s13206-025-00252-9 · Cited by 2
“…human primary pericytes and astrocytes Improved barrier properties (TEER, transporter expres - sions) with co-culture of neurovascular components [58] hiPSCs from Huntington’s disease (HD) patients hiBMECs for HD BBB Transcriptomic basis of HD-specific BBB dysfunction [59 ] hiPSC, human fetal…”
Human bone marrow-mesenchymal stem cells differentiation into brain-like endothelial cells
Soliman, Y., BARAN, G., & Mustafaoğlu, N. (2026) · TURKISH JOURNAL OF BIOLOGY · doi:10.55730/1300-0152.2786 · Cited by 2
“Previous studies have shown that RA significantly enhances the passive barrier properties of BMECs throughout differentiation (Lippmann et al., 2014a).”
InfluentialEngineering the Developmental Continuum: From Embryo-Like Structures to Functional Tissue Interfaces
Topal, T. (2026) · Methods in molecular biology · doi:10.1007/7651_2026_700 · Cited by 2
Human In Vitro Blood-Brain Barrier Models Derived from Stem Cells
Foreman, K. L., Palecek, S. P., & Shusta, E. V. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_9 · Cited by 2
Self-citationKörtge, A., Breitrück, A., Doß, S., Hofrichter, J., Nelz, S.-C., Krüsemann, H., Wasserkort, R., Fitzner, B., Hecker, M., Mitzner, S. R., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052590 · Cited by 2
“Here, it was used to assess the integrity of the endothelial hiPSC monolayer using a voltohmmeter (Millicell-ERS; Merck Millipore, Burlington, MA, USA).”
MethodThe Rise of Pluripotent Stem Cell-Derived Glia Models of Neuroinflammation
Kala, S., Strutz, A. G., & Katt, M. E. (2025) · Neurology International · doi:10.3390/neurolint17010006 · Cited by 2
Blood–brain barrier models in pre-clinical assessment of CNS-targeting cell and gene therapies
Stanimirovic, D. B., & Jezierski, A. (2019) · Cell and Gene Therapy Insights · doi:10.18609/cgti.2019.085 · Cited by 2
Biodegradable Nanoparticles for Specific Drug Transport
Danz, K., von Briesen, H., & Wagner, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-57456-7_13 · Cited by 2
Kara, A., Öztürk, N., & Vural, İ. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803796-6.00008-3 · Cited by 2
In vitro blood–brain barrier model derived from human iPS cells and its applications
Zhang, H., Yamaguchi, T., & Kawabata, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822231-7.00003-5 · Cited by 2
Abstracts from the 13th International Conference on Cerebral Vascular Biology (CVB 2019)
Santa-Maria, A. R., Kincses, A., Walter, F., Valkai, S., Dér, A., & Deli, M. A. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0135-8 · Cited by 2
Wasielewska, J. M., Bajracharya, R., Johnston, R. L., Chaves, J. C. S., Pébay, A., Oikari, L. E., Götz, J., Nisbet, R. M., & White, A. R. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.24.563706 · Cited by 2
“We previously demonstrated that Transwell inserts with 0.4 m pores, most commonly used in the iPSC-BBB models 34,49–52 , are suitable to assess small molecule (5 kDa) permeability, while those with pores of 3.0 m in diameter provide a more adequate in vitro system to study larger (150 kDa)…”
MethodInfluentialBouhrira, N. (2021) · Rowan Digitals Works (Rowan University) · Cited by 2
Chatard, M. (2017) · theses.fr (ABES) · doi:10.70675/6844582ez78dcz47d3zaef2za0a5cad4bbd8 · Cited by 2
Attia, T., El-Banna, H., & Aboali, S. (2021) · Journal of Current Veterinary Research · doi:10.21608/jcvr.2021.199437 · Cited by 1
Mehta, Y., Patel, D., Pervaiz, I., Bickel, U., & Al-Ahmad, A. J. (2024) · Journal of Chromatography Open · doi:10.1016/j.jcoa.2024.100198 · Cited by 1
Self-citationNelz, S.-C., Lück, E., Schölzel, A., Sauer, M., Heskamp, J., & Doß, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073334 · Cited by 1
“Differentiation was performed with minor modifications according to a protocol published by Lippmann et al. and Haferkamp et al. [20,50].”
Construction and Functional Evaluation of 2D and 3D Human Blood–Brain Barrier Models
Kurosawa, T., Kubo, Y., & Deguchi, Y. (2025) · Current human cell research and applications · doi:10.1007/978-981-97-9495-9_14 · Cited by 1
Srinivasan, B., & Kolli, A. R. (2025) · Neuromethods · doi:10.1007/978-1-0716-4474-4_8 · Cited by 1
Alexander, N. G., Hathcock, S. F., & Kim, B. J. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4674-8_1 · Cited by 1
Takeuchi, L. E., Lam, J., & Simmons, C. A. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02152-3 · Cited by 1
“Differentiation of ESCs and iPSCs to BECs have been previously described [17–19].”
Choi, E. S., Sahota, S., Burnham, E., Ding, Y., & Shusta, E. V. (2025) · Antibodies · doi:10.3390/antib14040102 · Cited by 1
“The iPSC-derived BMEC-like cells used for screening were differentiated in the same way as they were for the initial identification of the 46.1 antibody [24,53,54].”
InfluentialSelf-citationvascr: An R-based toolkit for rapid and robust analysis of cellular impedance sensing data
Hucklesby, J. J. W., Unsworth, C. P., Graham, E. S., & Angel, C. E. (2026) · European Biophysics Journal · doi:10.1007/s00249-026-01852-5 · Cited by 1
König, L., Khin, M., Puris, E., Petralla, S., Gericke, B., & Fricker, G. (2026) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2026.115111 · Cited by 1
Biomedical Materials and Fabrication Methods for Construction of In Vitro Neurovascular Unit Models
Xu, Y., Yu, W., Li, Y., & Zhang, L. (2026) · Materials · doi:10.3390/ma19173590 · Cited by 1
Construction and Applicability Scenarios of 3D Neurovascular Unit Models In Vitro
Yu, B., Shao, Z., Ni, Z., Gao, Y., Ding, Z., Jiang, W., Li, L., & Chu, L. (2026) · Biomolecules · doi:10.3390/biom16091250 · Cited by 1
“The construction of Transwell Chamber models is relatively straightforward, and subsequent analyses, such as fluorescently coupled dextran transmembrane transport assays (Figure 2G) and TEER measurements, are easily performed [84,88,89,98].”
Li, J., Gamboa, S. M., Chao, J. T., Heilshorn, S. C., & Wu, J. C. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01806-4 · Cited by 1
“Creating a more functional vasculature requires the addition of support cells such as pericytes, smooth muscle cells, neurons and fibroblasts, which help maintain endothelial homeostasis 75 and barrier stability 76 .”
In Vitro Modeling of Nervous System: Engineering of the Reflex Arc
Guo, X., Sommerhage, F., McAleer, C. W., Martin, C., Long, C. J., Wang, Y. I., Santhanam, N., Colón, A., Oleaga, C., & Hickman, J. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-31433-4_9 · Cited by 1
Gong, S., Li, Y., Su, W., Ding, Y., Lu, J., Dong, K., Hood, S. R., Zhang, W., & Terstappen, G. C. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218761355 · Cited by 1
In Vitro Blood-Brain Barrier Functional Assays in a Human iPSC-Based Model
Neal, E. H., Shi, Y., & Lippmann, E. S. (2019) · Neuromethods · doi:10.1007/978-1-4939-9228-7_1 · Cited by 1
Self-citationGray, K. M. (2019) · University Libraries (University of Maryland) · doi:10.13016/zi0m-cnsk · Cited by 1
Abstracts from the Virtual Symposium “Signal Transduction at the Blood–Brain Barriers”
(2021) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00286-9 · Cited by 1
Gomes, S. F. M. (2019) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-18855 · Cited by 1
Profka, A. (2023) · eScholarship@McGill (McGill) · doi:10.82308/43310 · Cited by 1
Potjewyd, G. (2021) · Research Explorer (The University of Manchester) · Cited by 1
Oller‐Salvia, B. (2015) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
In Vitro Chronic Neurotoxicity Assays: Present and Future Developments
Nagel, D. A., Hill, E. J., Woehrling, E. K., & Coleman, M. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99500-x
Wuest, D. (2014) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/w8v4-sd45
Development of an in-vitro epithelial-myofibroblast intestinal model
Patient, J. D. (2016) · Nottingham ePrints (University of Nottingham)
Brain-like endothelial cells derived from stem cells to study BBB development and targeting
de Almeida, C. O. P. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Tian, C. (2017) · DigitalCommons (California Polytechnic State University)
In Vitro Models of the Blood–Brain Barrier to Better Understand the Pathophysiology of Brain Edema
Al-Ahmad, A. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803196-4.00005-9
Self-citationLim, R. G. (2016) · eScholarship (California Digital Library)
Said, Z. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Ubogu, E. E. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-19515-1_8
Hinkel, S. (2020) · Digitale Bibliothek Braunschweig (Verbundzentrale Göttingen (VZG)) · doi:10.24355/dbbs.084-202008121326-0
Zhou, Y., Zheng, B., Ye, L., Zhang, H., Zhu, S., Zheng, X., Xia, Q.-H., He, Z., Wang, Q., Xiao, J., et al. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03149-1
Generation of cells to support drug discovery research using human iPS cells
Iwao, T., Hashita, T., & Matsunaga, T. (2020) · Drug Delivery System · doi:10.2745/dds.35.entrypoint
Overcoming the blood brain barrier: in vivo and in vitro perfusion model for delivery of Avidin
Ying, B. (2020) · Digital Repository Service (Northeastern University) · doi:10.17760/d20382871
Kinarivala, N., Morsy, A., Patel, R., Carmona, A. V., Sajib, M. S., Raut, S., Mikelis, C. M., Al-Ahmad, A. J., & Trippier, P. C. (2020) · ChemRxiv · doi:10.26434/chemrxiv.11493132
Self-citationLipton, S. A., & Dolatabadi, N. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732909303.793555051
Bonney, S. K., Mishra, S., Pleasure, S. J., & Siegenthaler, J. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814405-3.00043-6
Al-Ahmad, A. J., Pervaiz, I., Zahra, F. T., & Mikelis, C. M. (2022) · Research Square · doi:10.21203/rs.3.rs-1374943/v1
Self-citationConfigurable Models of the Neurovascular Unit
Mishra, Y., Sáez, J., & Owens, R. M. (2022) · Springer eBooks · doi:10.1007/978-3-031-11409-0_1
Sato, K., & Matsusaki, M. (2022) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.22-00161-2
In vitro BBB model derived from human iPS cells
Yamaguchi, T., & Kawabata, K. (2023) · Drug Delivery System · doi:10.2745/dds.38.42
Kurosawa, T., Sako, D., Kubo, Y., & Deguchi, Y. (2023) · Drug Delivery System · doi:10.2745/dds.38.117
P16-23: Blood-Brain Barrier Permeation in the Autologous Stem Cell-Derived Four-Organ-Chip
Wagegg, B. A., Koenig, L.-S., Ramme, A. P., Marx, U., & Dehne, E. (2023) · Toxicology Letters · doi:10.1016/s0378-4274(23)00714-2
Künstliche Hirngefäße zur Identifikation hirngängiger Wirkstoffe
Fengler, S., Kurkowsky, B., Heimlich, G., Fava, E., & Denner, P. (2023) · BIOspektrum · doi:10.1007/s12268-023-2066-9
Induced pluripotent stem cells for cardiovascular therapeutics: Progress and perspectives
Kizub, I. V. (2023) · Regulatory Mechanisms in Biosystems · doi:10.15421/10.15421/022366
Study of the antiepileptic drugs transport through the immature blood-brain barrier
Soares, R. V. (2015) · theses.fr (ABES) · doi:10.70675/81cb7f7fz0235z435cz87d2z90d8cd571f7a
Choublier, N. (2021) · theses.fr (ABES) · doi:10.70675/c24c7ff2z2531z4aa4z8aeaz1b3246b5d330
Analysis of transporter activity in an Alzheimer’s disease blood-brain barrier cell model
Chaves, J. (2024) · Queensland University of Technology · doi:10.5204/thesis.eprints.248279
Exploring Environmental Neurotoxicity Assessment Using Human Stem Cell-Derived Models
Kebieche, N., Ali, F. L., Seungae, Y., Ali, M., Lambert, C., & Soulimani, R. (2024) · Journal of Stem Cell Therapy and Transplantation · doi:10.29328/journal.jsctt.1001044
Zhang, P., Liu, M., Pei, S., Huang, H., Zhao, Z., Yang, L., Pan, W. L., Li, S., Bai, Q., Zhang, R., et al. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c13686
GENE THERAPY AT THE BLOOD-BRAIN BARRIER
Hede, E. (2024) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau770636156
In Vitro Models of the Blood–Brain Barrier to Study Multiple Sclerosis Pathogenesis
Fujisawa, M., Nishihara, H., & Engelhardt, B. (2025) · Current human cell research and applications · doi:10.1007/978-981-97-9495-9_13
Kopec, B. M., Ebert, E., Ulapane, K. R., Moral, M. E. G., & Siahaan, T. J. (2025) · Neuromethods · doi:10.1007/978-1-0716-4474-4_12
Mamana, J., Vollmuth, N., Kim, B. J., & Sin, J. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4674-8_9
Syeara, N., Mehta, Y., Karamyan, V. T., & Al-Ahmad, A. J. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4706-6_5
Self-citationDevelopment of human iPS cells-derived brain microvascular endothelial cells
Hashita, T. (2025) · Folia Pharmacologica Japonica · doi:10.1254/fpj.25043
Zucker, I. H. (2016) · F1000Research · doi:10.5256/f1000research.8859.r14067
Türker, E., Mier, M. S. A., Faber, J., Friedrich, M., Lamberger, Z., Weigelt, J., Stigloher, C., Murenu, N., Schaefer, N., Teßmar, J., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.74287
Jezierski, A., Huang, J., Haqqani, A. S., Haukenfrers, J., Liu, Z., Baumann, E., Sodja, C., Charlebois, C., Delaney, C. E., Star, A. T., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26592191
Shi, Y., Kim, H., Hamann, C. A., Rhea, E. M., Brunger, J. M., & Lippmann, E. S. (2022) · Figshare · doi:10.6084/m9.figshare.21184245
Self-citationLinville, R. M., Nerenberg, R. F., Grifno, G. N., Arevalo, D., Guo, Z., & Searson, P. C. (2022) · Figshare · doi:10.6084/m9.figshare.20208314
Gopinadhan, A., Hughes, J. M., Conroy, A. L., John, C. C., Canfield, S. G., & Datta, D. (2024) · Figshare · doi:10.6084/m9.figshare.26714833
Mathew, S. (2024) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-32247
Ozgür, B., Puris, E., Brachner, A., Appelt‐Menzel, A., Oerter, S., Balzer, V., Holst, M. R., Christiansen, R. F., Hyldig, K., Buckley, S. T., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24872982
Additional file 1 of Commentary on human pluripotent stem cell-based blood–brain barrier models
Lippmann, E. S., Azarin, S. M., Palecek, S. P., & Shusta, E. V. (2020) · Figshare · doi:10.6084/m9.figshare.13115217
Self-citationRaut, S., Patel, R., & Al-Ahmad, A. J. (2021) · Figshare · doi:10.6084/m9.figshare.13545554
Self-citationGopinadhan, A., Hughes, J. M., Conroy, A. L., John, C. C., Canfield, S. G., & Datta, D. (2024) · Figshare · doi:10.6084/m9.figshare.26714851
Gopinadhan, A., Hughes, J. M., Conroy, A. L., John, C. C., Canfield, S. G., & Datta, D. (2024) · Figshare · doi:10.6084/m9.figshare.26714830
Zhang, H., Yamaguchi, T., & Kawabata, K. (2024) · Figshare · doi:10.6084/m9.figshare.26565687
Aoki, H., Yamashita, M., Hashita, T., Iwao, T., & Matsunaga, T. (2020) · Figshare · doi:10.6084/m9.figshare.12050235
Stüdle, C., Nishihara, H., Wischnewski, S., Kulsvehagen, L., Perriot, S., Ishikawa, H., Schroten, H., Frank, S., Deigendesch, N., Du Pasquier, R., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24432018
Metadata
- Authors
- Lippmann, E. S., Al-Ahmad, A., Azarin, S. M., Palecek, S. P., & Shusta, E. V.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Palecek, Sean P.
- Shusta, Eric V.
- Venue
- Scientific Reports
- Published
- 2014-02-24
- Volume
- 4
- Issue
- 1
- Pages
- 4160-4160
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC3932448
- OpenAlex
- W2042883482
- Cited by
- 508
- References
- 51
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 45 · 2023: 55 · 2022: 56 · 2021: 45 · 2020: 58 · 2019: 54 · 2018: 41 · 2017: 34 · 2016: 26 · 2015: 22 · 2014: 10
- FWCI
- 15.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Science Foundation (NS083688)
- Cedars-Sinai Medical Center
- Beijing Municipal Education Commission
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism (AA020476, RC4AA020476)
- National Cancer Institute (P30CA014520)
- National Institute of General Medical Sciences (T32GM008505)
- National Institute of Neurological Disorders and Stroke (R01NS083688, NS083688)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- blood-brain barrier model, retinoic acid, human pluripotent stem cells, brain microvascular endothelial cells, pericytes, astrocytes, neural progenitor cells, tight junctions, adherens junctions, multidrug resistance protein, transendothelial electrical resistance, co-culture
- MeSH terms
- Astrocytes, Blood-Brain Barrier, Brain, Cell Differentiation, Cells, Cultured, Electric Conductivity, Endothelium, Vascular, Humans, Models, Biological, Neurons, Tretinoin, Coculture Techniques, Pericytes, Pluripotent Stem Cells, Neural Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.